REVANCE THERAPEUTICS INC shareholders Q4 2022

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 195 filers reported holding REVANCE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.

REVANCE THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
SIMPLEX TRADING, LLC 13,321$2450.00%
Allworth Financial LP 432$7,9750.00%
Cutler Group LLC / CA 4,600$10.00%
Cutler Group LLC / CA 800$00.00%
CANADA LIFE ASSURANCE Co 4,196$780.00%
Invesco Ltd. 66,435$1,226,3900.00%
NATIONAL BANK OF CANADA /FI/ 1,040$19,1880.00%
WOLVERINE TRADING, LLC 13,847$2560.00%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 30,598$564,8390.00%
ROYAL BANK OF CANADA 63,692$1,176,0000.00%
Lindbrook Capital, LLC 191$3,5260.00%
PRINCIPAL FINANCIAL GROUP INC 34,566$638,0880.00%
External links

This page lists REVANCE THERAPEUTICS INC's shareholders in Q4 2022. To view REVANCE THERAPEUTICS INC's shareholder history, click here.